Skip to content
Tuesday, October 13, 2026
Elite Core Exchange

Social Media Content Creators Fueling Unofficial Market for Unlicensed Weight-Loss Medication

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Several experts stated the demand for retatrutide could be connected to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or prison.

Service Response and Material Removal

According to TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The organization said it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.

Digital Trading Operations

Research also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.

Within moments of entering one community, a vendor posted contact information, where the majority of transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Item Information and Costs

Within these communities, messages show dark colored packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has previously seen individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious health risks”.

TA
About the author

Tamara Allen

A seasoned technology consultant with over 15 years of experience in digital transformation and business strategy across European markets.

Elite Core Exchange

Type to search articles.